While the causal role of inflammation in T2DM is uncertain, circulating pro-inflammatory proteins (e.g., IL-1, IL-6, IL-18, CRP, TNF-) are linked to T2DM risk [203]
And you can forget about everything I talked about in the last four or five slides
It is smart, individualized medicine
Laferrre B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, et al
GLP-1s were associated with lower risk of new substance use disorder diagnoses Across alcohol, cannabis, cocaine, nicotine, opioids, and other drug categories, people who started a GLP-1 medication were less likely to receive a new substance use disorder diagnosis over the following 3 years relative to those who started the comparison diabetes medication, sodium-glucose cotransporter-2 inhibitor